Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 72 of 82 for:    GRAZOPREVIR ANHYDROUS AND ELBASVIR

Transplanting Hepatitis C Lungs Into Negative Lung Recipients (SHELTER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03724149
Recruitment Status : Recruiting
First Posted : October 30, 2018
Last Update Posted : November 18, 2019
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
University of Pennsylvania

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : November 2021